PLoS ONE · 2011 · 55 citations · 32 references
MedicineGeneticsMolecular GeneticsGenetic EpidemiologyHuman GeneticsMedical GeneticsAdipose TissueCardiovascular DiseaseGenetic RiskGenotype-phenotype Association AnalysisHypertensive DisordersMetabolic SyndromeAssociation Study ReplicationGenetic Determinants Of HypertensionMetabolic Syndrome SusceptibilityReplication Study Design
OBJECTIVE: Cardiovascular risk increases with the presence of both metabolic syndrome (MetS) and hypertension (HTN). Although the adiponectin (ADIPOQ) gene has been reported to be involved in MetS, its association with HTN remained undetermined. This study aimed to investigate the association of ADIPOQ gene with the phenotypes of HTN and MetS. METHODS: A total of 962 participants from 302 families from the Taiwan young-onset hypertension genetic study were enrolled. Plasma adiponectin were measured, and association analysis was conducted by using GEE regression-based method. Another study, of 1448 unrelated participants, was conducted to replicate the association between ADIPOQ gene and variable phenotypes of MetS with or without HTN. RESULTS: Among 962 subjects from family samples, the lowest plasma adiponectin value was observed in MetS with HTN component (9.3±0.47 µg/ml) compared with hypertensives (13.4±0.74 µg /ml) or MetS without HTN (11.9±0.60 µg/ml, P<0.05). The SNP rs1501299 (G276T) in ADIPOQ gene was found associated with the presence of HTN in MetS (odds ratio for GG+GT vs. TT = 2.46; 95% CI: 1.14-5.3, p = 0.02), but not rs2241766 (T45G). No association of ADIPOQ gene with HTN alone or MetS without HTN was observed. The significant association of the SNP rs1501299 (G276T) with the phenotype of presence of HTN in MetS was confirmed (odds ratio for GG+GT vs. TT = 2.15; 95% CI: 1.1-4.3) in the replication study. CONCLUSIONS: ADIPOQ genetic variants were selectively and specifically associated with the concomitant presence of MetS and HTN, suggesting potential genetic linkage between MetS and HTN.
32
Longitudinal Data Analysis for Discrete and Continuous Outcomes
Scott L. Zeger, Kung‐Yee Liang · Biometrics · 1986 · 7.8K citations
Banting lecture 1988. Role of insulin resistance in human disease
Gerald M. Reaven · Diabetes · 1988 · 3.8K citations
Medicine, Endocrinology, Physiology +11
The Wellcome Trust Case Control Consortium, U.K.
Kaspar Mossman · Scientific American · 2008 · 2.7K citations